Industry Verticals »

All Categories

Insights »

About TMR »

Contrast Media Injectors Market

Contrast Media Injectors Market (Product Type: CT, MR, and Vascular Injectors; Application: Oncology, Cardiology, and Neurology) Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Contrast media are used to enhance quality of medical imaging such as CT, MRI, PET/CT and ultrasound. Their value has long been recognized by radiologists and is well illustrated by their frequent use in radiology departments worldwide. Contrast media injectors (CMI) are devices employed for injecting contrast media into the body to improve the visibility of tissues for a medical imaging procedures. Currently, market players are engaged in developing contrast injectors with enhanced capabilities such as improved patient safety, patient imaging data integration and higher specificity. Other major advances include shorter injection time, higher productivity, ease of operation and reduced radiation exposure to operators thereby ensuring efficient workflow and imaging with accurate results. The market is witnessing significant advances in the design of contrast media injectors shifting from single head injection system to the dual head injection that permit efficient use of contrast media. All these features are expected to provide impressive growth opportunities for the contrast media injectors market. On the other hand, side effects such as extravasations, air embolism and allergic reactions to contrast media might restrain the market growth. Complicated operations of the injectors with integrated technologies may further hamper the market growth.
 
CT injectors are the fastest growing segment owing to the large installed base of CT machines, low cost associated with scanning as compared to MRI and positron emission tomography (PET) along with a greater patient compliance. MR injectors and angio/vascular injectors constitute other major instrument segments that provide high reliability and accuracy in contrast injection. The uses of X-ray and ultrasound injectors are diminishing owing to the less reliability, complex workflow and technological restriction in imaging as compared to CT, MRI and other advanced techniques.
 
CT and MRI scanning procedures with contrast have increased in the past few years. The ability of CMI to control media flow and bolus chasing has added significant improvement in radiographic images. The most common indications for contrast-enhanced imaging include neurological, oncological, gastrointestinal and musculoskeletal diseases. The rising incidence of life threatening diseases, trauma and complex fractures has increased the use of these scanning techniques to investigate doubtful clinical manifestations. Presently, CT and MRI scanning find numerous applications in most of the neurological disorders. Neuroimaging (CT, MRI and others) with contrast are best suited for neurological investigations such as brain injuries, intracranial hemorrhage, tumor and acute neurological changes. A study on neuroimaging in brain injury published in NeuroRX estimated that around 1.6 million head injuries occur in the U.S. each year and medical imaging is required in 48% (moderate to severe) of these cases.
 
Geographical landscape elucidates the market trends for North America, Europe, Asia-Pacific and Rest of the World (RoW). North America and Europe dominated the contrast media injectors market in 2013 accounting for around more than 60% of the total market. The dominance of North America and Europe can be attributed to the high adoption of contrast media injectors (CMI) in radiology procedures by hospitals and clinicians as compared to other regions. These regions continue to dominate the market due to the high prevalence of cardiovascular and neurological disorders. According to the Heart Foundation in the U.S., an estimated 80 million people in the U.S. have one or more types of heart disease. Additionally, large numbers of traumatic and non-traumatic injuries helped the market grow consistently in the recent past. 
 
Asia Pacific is expected to show significant growth, accounting for approximately 25% of the total market in 2020. The contrast media injectors market in Asia Pacific is highly competitive and dominated by only a few market players such as Nemoto Kyorindo Co., Ltd. The market is expected to grow at a CAGR of 6.5% through 2020. Growth in the region is anticipated primarily due to economic growth in the region, which has led to increased disposable income and consequently, increased affordability of sophisticated imaging technology. Moreover, a large population base and growing geriatric population that is more prone to cardiovascular and certain neurological disorders would lead to a large potential patient base. Countries such as China, India and Australia exhibit significant growth prospect in terms of rapid increase in the installation of medical imaging equipment and procedures. According to the China Association of Medical Equipment, 11,242 CT units were operational in 2010 compared to 10,101 CT units in 2009. In 2010, around 1,141 CT units were sold in China; of those, 262 units were refurbished CT machines. With a population of more than 1.3 billion individuals and the existence of over 18,000 hospitals, the medical imaging market in China is expected to grow exponentially in the next few years.
 
The global market for contrast media injectors market was valued at USD 630.1 million in the year 2013 and it is anticipated to reach USD 886.7million by 2020, growing at a CAGR of 5.0% from 2014 to 2020. The overall contrast media injectors market is consolidated characterized by the presence of few established players accounting for more than 70% of the total market share. Bracco Imaging S.p.A., Mallinckrodt Pharmaceuticals, Medrad, Inc. ulrich Medical GmbH, VIVID IMAGING, Medtron AG and Nemoto Kyorindo are some of the key players operating in this market.
     
    Chapter 1 Introduction
    1.1 Report Description
    1.2 Research Methodology
          1.2.1 Sources
                  1.2.1.1 Secondary Research
                  1.2.1.2 Primary Research
                  1.2.1.3 Assumptions
    1.3 Market Segmentation
    1.4 List of Abbreviations
     
    Chapter 2 Executive Summary
    2.1 Comparative Analysis: Global Contrast Media Injectors Market, by Geography, 2013 & 2020 (Value %)
     
    Chapter 3 Market Overview
    3.1 Introduction
    3.2 Event Impact Analysis
    3.3 Market Dynamics
    3.4 Market Drivers
          3.4.1 Consistent rise in imaging procedures (CT, MRI and others) create a demand for efficient contrast media injectors and drive market growth
          3.4.2 Technological advances leading to efficient workflow would increase the acceptance of contrast media injectors
          3.4.3 Increasing preference for pre-diagnosis leading to increased imaging, that enhances the use of contrast media injectors
    3.5 Market Restraints
          3.5.1 High cost associated with technologically advanced contrast media injectors could hamper market growth
          3.5.2 Adverse reactions associated with contrast media could restrain market growth
    3.6 Market Opportunities
    3.7 Value Chain Analysis: Global Contrast Media Injectors Market
    3.8 Regulatory and Reimbursement Overview
    3.9 Patent Landscape : Contrast Media Injectors Market
    3.10 Porter’s Five Forces Analysis for the Global Contrast Media Injectors Market
          3.10.1 Bargaining power of suppliers
          3.10.2 Bargaining power of buyers
          3.10.3 Threat of substitutes
          3.10.4 Threat of new entrants
          3.10.5 Competitive rivalry
    3.11 Market Attractiveness Analysis: Global Contrast Media Injectors Market, by Geography
    3.12 Competitive Landscape
          3.12.1 Global Contrast Media Injectors Market Share by Key Players, 2013 (Value %)
     
    Chapter 4 Global Contrast Media Injectors Market, by Type
    4.1 Overview
          4.1.1 Global Contrast Media Injectors Market Revenue, by Type, 2012 - 2020 (USD Million)
    4.2 Comparative Analysis: Global Contrast Media Injectors Market, by Type, 2013 & 2020 (Value %)
    4.3 Computed Tomography (CT)  Injectors
          4.3.1 Global CT Injectors Market Revenue, 2012- 2020 (USD Million)
    4.4 Magnetic Resonance Imaging (MRI) Injectors
          4.4.1 Global MR Injectors Market Revenue, 2012- 2020 (USD Million)
    4.5 Angiography, Interventional and Vascular Injectors
          4.5.1 Global Vascular Injectors Market Revenue, 2012 - 2020 (USD Million)
    4.6 Others
          4.6.1 Global Other Injectors Market Revenue, 2012 - 2020 (USD Million)
     
    Chapter 5 Global Contrast Media Injectors Market, by Application
    5.1 Overview
          5.1.1 Global Contrast Media Injectors Market Revenue, by Application, 2012 – 2020 (USD Million)
    5.2 Comparative Analysis: Global Contrast Media Injectors Market, by Application, 2012 – 2020 (Value %)
    5.3 Cardiology
          5.3.1 Global Cardiology Application Market Revenue, 2012- 2020 (USD Million)
    5.4 Neurology
          5.4.1 Global Neurology Application Market Revenue, 2012- 2020 (USD Million)
    5.5 Oncology
          5.5.1 Global Oncology Application Market Revenue, 2012- 2020 (USD Million)
    5.6 Others
          5.6.1 Global Others Application Market Revenue, 2012- 2020 (USD Million)
     
    Chapter 6 Global Contrast Media injectors Market, by Geography
    6.1 Overview
          6.1.1 Global Contrast Media Injectors Market Revenue, by Geography, 2012 – 2020 (USD Million)
    6.2 North America
          6.2.1 North America Contrast Media Injectors Market Revenue, 2012 – 2020 (USD Million)
    6.3 Europe
          6.3.1 Europe Contrast Media Injectors Market Revenue, 2012 – 2020 (USD Million)
    6.4 Asia-Pacific
          6.4.1 Asia-Pacific Contrast Media Injectors Market Revenue, 2012 – 2020 (USD Million)
    6.5 Rest of the World (RoW)
          6.5.1 RoW Contrast Media Injectors Market Revenue, 2012 – 2020 (USD Million)
     
    Chapter 7 Recommendations
    7.1 Recommendations
          7.1.1 Listing of injectors with major imaging equipment (CT, MRI) manufacturers by adopting product bundling strategies
          7.1.2 Partnership with refurbished medical imaging supplier, and parts & services providers
          7.1.3 Strategy for geographical expansion
                   7.1.3.1 North America
                   7.1.3.2 Europe
                   7.1.3.3 Asia Pacific and Rest of the World
     
    Chapter 8 Company Profiles
    8.1 Bracco Imaging S.p.A.
          8.1.1 Company Overview
          8.1.2 Financial Overview
          8.1.3 Product Portfolio
          8.1.4 Business Strategies
          8.1.5 Recent Developments
    8.2 Guerbet Group
          8.2.1 Company Overview
          8.2.2 Financial Overview
          8.2.3 Product Portfolio
          8.2.4 Business Strategies
          8.2.5 Recent Developments
    8.3 Mallinckrodt Pharmaceuticals
          8.3.1 Company Overview
          8.3.2 Financial Overview
          8.3.3 Product Portfolio
          8.3.4 Business Strategies
          8.3.5 Recent Developments
    8.4 Medrad, Inc.
          8.4.1 Company Overview
          8.4.2 Product Portfolio
          8.4.3 Financial Overview
          8.4.4 Business Strategies
          8.4.5 Recent Developments
    8.5 MEDTRON AG
          8.5.1 Company Overview
          8.5.2 Financial Overview
          8.5.3 Product Portfolio
          8.5.4 Business Strategies
          8.5.5 Recent Developments
    8.6 Nemoto Kyorindo Co., Ltd.
          8.6.1 Company Overview
          8.6.2 Financial Overview
          8.6.3 Product Portfolio
          8.6.4 Business Strategies
          8.6.5 Recent Developments
    8.7 ulrich Medical GmbH & Co. KG
          8.7.1 Company Overview
          8.7.2 Financial Overview
          8.7.3 Product Portfolio
          8.7.4 Business Strategies
          8.7.5 Recent Developments
    8.8 VIVID IMAGING Technologies
          8.8.1 Company Overview
          8.8.2 Financial Overview
          8.8.3 Product Portfolio
          8.8.4 Business Strategies
          8.8.5 Recent Developments
    List of Tables
     
    TABLE 1 List of Abbreviations
    TABLE 2 Market Snapshot: Global Contrast Media Injectors Market
    TABLE 3 Global Contrast Media Injectors Market Revenue, by Type, 2012 – 2020 (USD Million)
    TABLE 4 Global Contrast Media Injectors Market Revenue, by Application, 2012 – 2020 (USD Million)
    TABLE 5 Global Contrast Media Injectors Market Revenue, by Geography, 2012 – 2020 (USD Million)

    List of Figures

     

    FIG. 1 Contrast Media Injectors Market Segmentation

    FIG. 2 Global Contrast Media Injectors Market, by Type, 2013 (USD Million)

    FIG. 3 Global Contrast Media Injectors Market, by Application, 2013 (USD Million)

    FIG. 4 Comparative Analysis: Global Contrast Media Injectors Market, by Geography, 2013 & 2020 (Value %)

    FIG. 5 Global Contrast Media Injectors Market Value Chain Analysis

    FIG. 6 Porter’s Five Forces Analysis: Global Contrast Media Injectors Market

    FIG. 7 Market Attractiveness Analysis: Global Contrast Media Injectors Market, by Geography, 2013

    FIG. 8 Contrast Media Injectors: Global Market Share by Key Players, 2013 (Value %)

    FIG. 9 Comparative Analysis: Global Contrast Media Injectors Market, by Type, 2013 & 2020 (Value %)

    FIG. 10 Global CT Injectors Market Revenue, 2012 – 2020 (USD Million)

    FIG. 11 Global MR Injectors Market Revenue, 2012 – 2020 (USD Million)

    FIG. 12 Global Vascular Injectors Market Revenue, 2012 - 2020 (USD Million)

    FIG. 13 Global Other Injectors Market Revenue, 2012 - 2020 (USD Million)

    FIG. 14 Comparative Analysis: Global Contrast Media Injectors Market, by Application, 2013 & 2020 (Value %)

    FIG. 15 Global Cardiology Application Market Revenue, 2012 – 2020 (USD Million)

    FIG. 16 Global Neurology Application Market Revenue, 2012 – 2020 (USD Million)

    FIG. 17 Global Oncology Application Market Revenue, 2012 – 2020 (USD Million)

    FIG. 18 Global Others Application Market Revenue, 2012 – 2020 (USD Million)

    FIG. 19 North America Contrast Media Injectors Market Revenue, 2012 – 2020 (USD Million)

    FIG. 20 Europe Contrast Media Injectors Market Revenue, 2012 – 2020 (USD Million)

    FIG. 21 Asia-Pacific Contrast Media Injectors Market Revenue, 2012 – 2020 (USD Million)

    FIG. 22 RoW Contrast Media Injectors Market Revenue, 2012 – 2020 (USD Million)

    FIG. 23 Annual Revenue by Geography: Bracco Imaging S.p.A, Inc., 2013 (USD Million)

    FIG. 24 Annual Revenue by Products: Bracco Imaging S.p.A, Inc., 2013 (USD Million) Conversion Rate: 1 Euro = USD 1.246

    FIG. 25 Guerbet group: Annual Revenue, 2011 – 2013 (USD Million)

    FIG. 26 Annual Revenue Mallinckrodt, 2011-2013 (USD Million)

    FIG. 27 Annual Revenue Mallinckrodt (By Segment), 2011-2013 (USD Million)

Copyright © Transparency Market Research, Inc. All Rights reserved

Contrast Media Injectors Market

Schedule a Call